Error loading player: No playable sources found

Player size: small large

Short Talk: Elevated Systemic Myeloid-Derived Suppressor Cells and Interleukin 8 Correlate with Increased Incidence of Venous Thromboembolism in Cancer Patients Receiving Immune-Checkpoint Inhibitors

Date

September 23, 2020

This product is not available for individual purchase, but it is available as part of the following products:

Thumbnail for eSymposia | Myeloid Cells and Innate Immunity in Solid Tumors - Regular Rate

eSymposia | Myeloid Cells and Innate Immunity in Solid Tumors - Regular Rate

Speaker

Shadi Swaidani, PhD

Cleveland Clinic Foundation

Tracks

Targeting Myeloid Cells in Cancer Therapy II

Related Products

Thumbnail for Short Talk: Extracellular Vesicles Derived from a Commensal Bacteria Enhance Anticancer Immunity by Modulating Tumor Infiltrating Immune Cells

Short Talk: Extracellular Vesicles Derived from a Commensal Bacteria Enhance Anticancer Immunity by Modulating Tumor Infiltrating Immune Cells

Thumbnail for Targeting Myeloid Cells in Cancer Therapy II

Targeting Myeloid Cells in Cancer Therapy II

Thumbnail for Targeting PI3K-gamma with IPI-549, a Tumor Macrophage-Reprogramming Small Molecule, in Patients with Advanced Solid Tumors

Targeting PI3K-gamma with IPI-549, a Tumor Macrophage-Reprogramming Small Molecule, in Patients with Advanced Solid Tumors

Thumbnail for Mechanisms Governing Accumulation of Macrophages in Cancer

Mechanisms Governing Accumulation of Macrophages in Cancer

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.